Ariela Benigni Selected Research

Cicatrix (Scar)

11/2014	Key fibrogenic mediators: old players. Renin-angiotensin system.
1/2004	Cellular responses to protein overload: key event in renal disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ariela Benigni Research Topics

Disease

36	Proteinuria 02/2024 - 05/2001
26	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 07/2003
16	Kidney Diseases (Kidney Disease) 02/2024 - 09/2002
16	Inflammation (Inflammations) 02/2024 - 10/2003
13	Fibrosis (Cirrhosis) 01/2023 - 02/2006
12	Chronic Renal Insufficiency 02/2024 - 01/2007
11	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 11/2007
9	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2024 - 05/2001
9	Albuminuria 07/2022 - 02/2010
9	Hypertension (High Blood Pressure) 01/2020 - 09/2002
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 07/2010
8	Disease Progression 01/2021 - 07/2003
7	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2023 - 05/2008
7	COVID-19 06/2023 - 01/2020
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2011
6	Glomerulonephritis 01/2022 - 06/2006
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 03/2007
5	Thrombosis (Thrombus) 01/2022 - 01/2002
4	Infections 02/2024 - 04/2000
4	Atypical Hemolytic Uremic Syndrome 01/2022 - 01/2019
4	Heart Failure 12/2019 - 12/2002
4	Neoplasms (Cancer) 01/2018 - 04/2000
3	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 12/2023
3	Microvascular Rarefaction 07/2022 - 11/2012
3	Hemolytic-Uremic Syndrome 01/2022 - 12/2006
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2021 - 05/2008
3	Lupus Nephritis 06/2017 - 05/2007
3	IGA Glomerulonephritis (IGA Nephropathy) 06/2017 - 07/2003
3	Sclerosis 01/2016 - 01/2006
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 02/2024 - 01/2015
2	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 10/2022 - 12/2019
2	Rare Diseases (Rare Disease) 01/2022 - 01/2021
2	Renal Insufficiency (Renal Failure) 01/2022 - 01/2021
2	Anemia 01/2021 - 05/2012
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021 - 01/2018
2	Reperfusion Injury 01/2020 - 08/2011
2	Hypertrophy 12/2019 - 01/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2016
2	Cicatrix (Scar) 11/2014 - 01/2004
2	Body Weight (Weight, Body) 03/2013 - 12/2009
2	Delayed Graft Function 08/2011 - 05/2005

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2001
13	Angiotensin IIIBA 01/2020 - 05/2001
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2023 - 07/2003
12	Sirtuin 3IBA 01/2023 - 01/2010
10	Complement System Proteins (Complement)IBA 02/2024 - 01/2019
10	nephrinIBA 01/2022 - 05/2001
8	AntibodiesIBA 12/2023 - 07/2003
7	Lisinopril (Prinivil)FDA LinkGeneric 01/2020 - 05/2001
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 07/2003
5	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 11/2007
5	MicroRNAs (MicroRNA)IBA 06/2017 - 09/2012
4	SirtuinsIBA 02/2024 - 05/2011
4	Phospholipase A2 ReceptorsIBA 01/2024 - 10/2015
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2010
4	Streptozocin (Streptozotocin)FDA Link 01/2016 - 01/2006
4	Endothelins (Endothelin)IBA 01/2011 - 12/2002
4	Transforming Growth Factor beta (TGF-beta)IBA 03/2007 - 07/2003
3	AutoantibodiesIBA 12/2023 - 08/2011
3	AntigensIBA 12/2023 - 08/2011
3	Messenger RNA (mRNA)IBA 01/2023 - 07/2003
3	eculizumab FDA Link 01/2022 - 01/2019
3	Complement Factor H (Factor H)IBA 01/2019 - 01/2019
3	Endothelin-1 (Endothelin 1)IBA 03/2015 - 09/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2013 - 01/2004
2	CreatinineIBA 12/2023 - 01/2019
2	EnzymesIBA 12/2023 - 05/2008
2	Rituximab (Mabthera)FDA Link 12/2023 - 10/2015
2	SARS-CoV-2 spike proteinIBA 06/2023 - 01/2023
2	SteroidsIBA 04/2023 - 12/2021
2	superoxide dismutase 2IBA 10/2022 - 08/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2021
2	Shiga Toxin (Shigella Toxin)IBA 01/2022 - 12/2006
2	angiotensin I (1-7)IBA 01/2022 - 10/2019
2	NestinIBA 01/2022 - 12/2009
2	Erythropoietin FDA Link 01/2021 - 05/2012
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2018
2	CollagenIBA 01/2020 - 01/2012
2	Oxygen (Dioxygen)IBA 01/2020 - 05/2012
2	LigandsIBA 10/2019 - 10/2009
2	Peptides (Polypeptides)IBA 10/2019 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 10/2017
2	Bovine Serum AlbuminIBA 01/2018 - 10/2003
2	AntioxidantsIBA 10/2017 - 03/2013
2	Abatacept (Orencia)FDA Link 04/2016 - 01/2014
2	Immunoglobulin G (IgG)IBA 05/2015 - 08/2011
2	Type 1 Angiotensin ReceptorIBA 11/2014 - 10/2004
2	bardoxolone methylIBA 02/2014 - 03/2013
2	Ramipril (Altace)FDA LinkGeneric 01/2013 - 11/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2010 - 01/2007
2	candesartanIBA 11/2010 - 06/2006
2	Rosuvastatin Calcium (Crestor)FDA Link 11/2010 - 01/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2009 - 05/2007

Therapy/Procedure

23	Therapeutics 01/2024 - 07/2003
7	Kidney Transplantation 01/2020 - 11/2008
3	Transplantation 01/2020 - 08/2008
3	Organ Transplantation 01/2008 - 04/2000
2	Precision Medicine 01/2024 - 07/2018
2	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2023 - 01/2021
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2017 - 05/2014